Abstract:Background: Benzodiazepines (BZDs) and Z-drugs have been widely used in clinical practice and there have been limited data from large populations about hazardous BZDs and Z-drugs use and its correlates in patients with mental disorder. The study aimed to assess the current status of hazardous BZDs and Z-drugs use and its related factors via analysis of prescriptions in outpatient psychiatric settings in China.Methods: The study included outpatients who were prescribed at least one BZDs or Z-drugs from 5 psychiatric settings in the east, central and west regions of China in 2018. Demographic and prescription information were extracted from the electronic prescription dispensing database. We defined the co-occurence of overdose [>40mg Diazepam Milligram Equivalence (DME)] and long-term use (>consecutive 90 days) as the hazardous hypnotics use, and patients whose recorded diagnoses did not meet any indications in Chinese FDA as the over-indication users. In addition, 200 patients who were detected as hazardous users in one of the hospitals in the east region were randomly selected for follow-up interview to confirm the actual situation.Findings: Among the 720 054 outpatients in 2018, 164 450 (22·8%) patients had at least one BZDs or Z-drugs prescription. Most of the patients were females (63·6%) and were aged 18 to 64 (76·2%). Of the total patients, 55·9% patients were prescribed with over-indication use and 3% were defined as hazardous users. Multivariate logistic regression shown that factors associated with a greater likelihood of hazardous use were older age (aOR[>65]: 5·05; 95%CI: 3·24-8·40), male gender (aOR: 1·20; 95%CI: 1·13-1·28), west region (aOR 1·13; 95%CI: 1·05-1·22), over-indications use (aOR 3·09; 95%CI: 2·82-3·39), a more frequent outpatient visit (aOR 1·06; 95%CI: 1·06-1·07), a greater number of different doctors visits (aOR 1·23; 95%CI: 1·22-1·24), and patients diagnosed particularly as Behavioral syndromes associated with physiological disturbances and physical factors (aOR 3·65; 95%CI:3·07-4·30), Epilepsy and recurrent seizures (aOR 5·22; 95%CI: 4·29-6·30) and Sleep disorders (aOR 1·85; 95%CI: 1·67-2·04). 98·5% (197/200) of patients at hazardous use risk cannot be effectively accessed because they registered the wrong contact information in the outpatient system (72·5%) or refused to be followed up (26%), and one of three patients who completed the interview met the DSM-5 criteria for Sedative hypnotics dependence syndrome.Interpretation: Sedative hypnotic drugs are commonly used clinically, and there are relatively large proportion of over-indication users in outpatients psychiatric settings in China. Whereas, a small proportion of patients at risk of hazardous BZDs and Z-drugs use (long-term and high-dose use) were detected by prescription data. The question raised by this study is how to use prescription data to support improvements in clinical practice.Funding: National Natural Science Foundation of China, Clinical Research Center of Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center Clinical Research Center and Shanghai Municipal Health Commission.Declaration of Interest: None to declare. Ethical Approval: The study was approved and monitored by Shanghai Mental Health Center (permission number: 2019-22)

New and Persistent Sedative-Hypnotic Use after Adjuvant Chemotherapy for Breast Cancer.

Hypnosis Sedation Reduces the Duration of Different Side Effects of Cancer Treatments in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Evaluating the Impact of Pharmacists on Reducing Use of Sedative/Hypnotics for Treatment of Insomnia in Long-Term Care Facility Residents.

Prescribed sedative and other psychotropic medication use among clients attending alcohol and other drug treatment

Characterising incident opioid use among incident users of prescription sedative hypnotics: A national cohort study

Prevalence and Safety of Off-Label Use of Chemotherapeutic Agents in Older Patients With Breast Cancer: Estimates From SEER-Medicare Data

Status and manifestations of sleep disorders and the status of drugs used to help fall sleep in Chinese breast cancer women at initial diagnosis and during chemotherapy

0914 Retrospective Review of Sedative Use on Hospitalized Patients at Risk for OSA

Hazardous Use of Benzodiazepine and Z-Drugs in Psychiatric Clinics in China: An Electronic Prescription Database Study

Distinct Trajectories of Fatigue and Sleep Disturbance in Women Receiving Chemotherapy for Breast Cancer

Sedative drug prescription patterns in Danish adults from 2002 through 2021. A register-based cohort study

Hypnosis on patients treated with adjuvant chemotherapy for breast cancer: A feasibility study

Sedative-hypnotics and osteoporotic fractures: A systematic review of observational studies with over six million individuals

Trends, correlates, and disease patterns of sedative-hypnotic use among elderly persons in Taiwan

Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30

A Novel Research Method for Determining Sedative Exposure in Critically Ill Patients

Associations between acupuncture and uses of opioids and neuropsychiatric medication following chemotherapy-induced peripheral neuropathy among patients with breast cancer.

Benzodiazepine Utilization in Ischemic Stroke Survivors: Analyzing Initial Excess Supply and Longitudinal Trends

Effect of New York State Regulatory Action on Benzodiazepine Prescribing and Hip Fracture Rates

Potentially inappropriate medication use in older patients with breast and colorectal cancer

Non-benzodiazepine Hypnotics and Police-Reported Motor Vehicle Crash Risk among Older Adults: A Sequential Target Trial Emulation